Scarica l'app Stockscreener
8.22
0.86%
0.07
Dopo l'orario di chiusura:
8.20
-0.02
-0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Is Novavax (NVAX) Now Pricing In Too Much Risk After Its Recent Volatility - Yahoo Finance
Therapeutics Stocks Q4 Earnings: AbbVie and Novavax Performance Analysis as of April 2026News and Statistics - IndexBox
Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead - Insider Monkey
FY2028 EPS Estimates for Novavax Cut by Zacks Research - MarketBeat
1 Cash-Heavy Stock to Target This Week and 2 We Ignore - The Globe and Mail
Novavax Soars After Covid Vaccine Secures Full FDA Approval - MSN
Novavax (NVAX) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
5 Most Undervalued Healthcare Stocks to Buy Now - Insider Monkey
Is Novavax (NVAX) stock a good investment this year | Novavax Inc. posts 122% EPS beat vs expected lossProfit Guidance - Xã Thanh Hà
US CDC will not publish report showing COVID vaccine effectiveness - Reuters
COVID vaccine report on cutting hospital visits blocked from publication in CDC journal - Seeking Alpha
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs? - TradingView
Will Higher Costs & Lower Occupancy Impact HCA's Q1 Earnings? - TradingView
Therapeutics Q4 Earnings: Novavax (NASDAQ:NVAX) Simply the Best - Yahoo Finance
H.C. Wainwright reiterates Novavax stock rating on vaccine study By Investing.com - Investing.com India
NVAX Technical Analysis | Trend, Signals & Chart Patterns | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In - MedCity News
Novavax’s COVID vaccine becomes 4th available for use in Japan - 朝日新聞
Novavax Urged to Probe Studies Using Monkeys From Filthy Lab After PETA Exposé - PETA
Novavax (NVAX) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax (NVAX) EVP R&D discloses options, RSUs and shares on Form 3 - Stock Titan
Discipline and Rules-Based Execution in NVAX Response - Stock Traders Daily
Novavax Inc stock (US6707721049): Is its vaccine pipeline strong enough to unlock new upside? - AD HOC NEWS
SHAH CAPITAL MANAGEMENT Increases Stake in Novavax Inc - GuruFocus
Novavax Inc stock (US6707721049): Is its vaccine pivot strong enough to unlock new upside? - AD HOC NEWS
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Synlogic and Novavax Face Off in Financial Analysis - National Today
Novavax, Inc. Revenue Breakdown – BSESOF:NVV1 - TradingView — Track All Markets
Why Novavax (NVAX) Is Up 5.5% After Activist Pressure Meets New R&D Leadership And What's Next - Yahoo Finance
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is Novavax (NVAX) Being Pulled Between R&D Ambitions and Activist Demands for Discipline? - simplywall.st
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Novavax (NVAX): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
US CDC delays publishing report showing COVID vaccine benefits, WaPo reports - Reuters
B. Riley Raises Price Target on Novavax to $18 from $16, Keeps Buy Rating - marketscreener.com
Novavax (NVAX) Receives a Sell from Bank of America Securities - The Globe and Mail
Shah Capital Pushes for Changes at Novavax (NVAX) - GuruFocus
Why is NVAX stock surging today? - MSN
Shah Capital Blasts Novavax Strategy In New Letter To Board - Citeline News & Insights
Shah Capital's Plan to Vote Against Novavax Board Nominees | PharmExec - Pharmaceutical Executive
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees - Pharmaceutical Executive
Investor calls for Novavax to slash costs, cut board as vaccine sales disappoint - The Business Journals
Shah Capital intends to vote against Novavax's board nominees, executive compensation - Reuters
Activist investor revives campaign to overhaul Novavax board - BioPharma Dive
Novavax Faces Shareholder Revolt As Shah Capital Criticizes StrategyNovavax (NASDAQ:NVAX) - Benzinga
3 Reasons NVAX is Risky and 1 Stock to Buy Instead - Yahoo Finance
Novavax rises as Shah Capital calls for changes (NVAX:NASDAQ) - Seeking Alpha
Assessing Novavax (NVAX) Valuation After Renewed Focus On Covid And Malaria Vaccine Deals - Yahoo Finance
Novavax stock surges as activist pushes for board changes By Investing.com - Investing.com Canada
Why Is NVAX Stock Surging Today? - Stocktwits
4.01%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):